In recent times myopia management has attracted significant interest from researchers and eyecare practitioners, with representative bodies such as the World Council of Optometry calling for myopia management to be part of the standard of care for myopic patients...
The emergence of new therapies to limit myopia progression offers eyecare practitioners (ECPs) the opportunity to deliver better health outcomes for their patients. Despite growing calls for myopia control to become the new standard of care,(1)uptake of these new treatments by practitioners is still limited....
While for many, myopia is an optically corrected inconvenience, for an ever-increasing minority, myopia is a factor leading to more severe vision disorders and visual impairment in mid to later life. Myopia is a recognised growing health issue in East Asia, where large-scale measurement...
Lutein, zeaxanthin and meso-zeaxanthin preferentially accumulate in neural tissue, including the macula, where they form macular pigment. Macular pigment has been extensively researched in terms of ocular health and disease prevention, particularly in relation to age-related macular degeneration (AMD). A less obvious target for macular...
Scientific and industrial innovators have responded to the threat posed by myopia. We now have a rapidly increasing range of treatments available which have been shown to delay myopia onset, reduce or eliminate the progression of myopia in some children and thereby reduce the risk...
Up to 50% of people in the Northern Hemisphere suffer from Dry Eye Disease (DED), with or without symptoms. These impressive numbers, published in the TFOS DEWS II Report Executive Summary, can be even more substantial. In some populations, DED prevalence was higher and more...
According to a recent meta-analysis of published studies, approximately 11% of COVID-19 patients have exhibited direct ocular effects (1). Typically, the complications appear to be relatively mild and short-term. ...
We will now examine how a successful public health strategy for myopia might be implemented, and what policy measures might generate sufficient impact to reverse the myopia epidemic....
The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia....
